397 related articles for article (PubMed ID: 30003679)
1. Serum uric acid levels and decreased estimated glomerular filtration rate in patients with type 2 diabetes: A cohort study and meta-analysis.
Wang J; Yu Y; Li X; Li D; Xu C; Yuan J; Wei S; Li X; Yang K; Zheng D; Tang Y; Yang H; Wu T; He M
Diabetes Metab Res Rev; 2018 Oct; 34(7):e3046. PubMed ID: 30003679
[TBL] [Abstract][Full Text] [Related]
2. The association between elevated serum uric acid level and an increased risk of renal function decline in a health checkup cohort in China.
Cao X; Wu L; Chen Z
Int Urol Nephrol; 2018 Mar; 50(3):517-525. PubMed ID: 29094330
[TBL] [Abstract][Full Text] [Related]
3. Serum uric acid to creatinine ratio is a useful predictor of renal dysfunction among diabetic persons.
Kawamoto R; Ninomiya D; Kikuchi A; Akase T; Kasai Y; Ohtsuka N; Kumagi T
Diabetes Metab Syndr; 2019; 13(3):1851-1856. PubMed ID: 31235105
[TBL] [Abstract][Full Text] [Related]
4. Association of serum uric acid levels with the incident of kidney disease and rapid eGFR decline in Chinese individuals with eGFR > 60 mL/min/1.73 m
Zhou F; Yu G; Wang G; Liu Y; Zhang L; Wang W; Chen N
Clin Exp Nephrol; 2019 Jul; 23(7):871-879. PubMed ID: 30734168
[TBL] [Abstract][Full Text] [Related]
5. Serum uric acid to creatinine ratio: A predictor of incident chronic kidney disease in type 2 diabetes mellitus patients with preserved kidney function.
Gu L; Huang L; Wu H; Lou Q; Bian R
Diab Vasc Dis Res; 2017 May; 14(3):221-225. PubMed ID: 28183204
[TBL] [Abstract][Full Text] [Related]
6. Increased Serum Uric Acid Level Is a Risk Factor for Left Ventricular Hypertrophy but Not Independent of eGFR in Patients with Type 2 Diabetic Kidney Disease.
Zeng C; Cheng D; Sheng X; Jian G; Fan Y; Chen Y; Li J; Bao H; Wang N
J Diabetes Res; 2017; 2017():5016093. PubMed ID: 28713836
[TBL] [Abstract][Full Text] [Related]
7. Serum uric acid, the metabolic syndrome, and the risk of chronic kidney disease in patients with type 2 diabetes.
Sheikhbahaei S; Fotouhi A; Hafezi-Nejad N; Nakhjavani M; Esteghamati A
Metab Syndr Relat Disord; 2014 Mar; 12(2):102-9. PubMed ID: 24447037
[TBL] [Abstract][Full Text] [Related]
8. The association between time-mean serum uric acid levels and the incidence of chronic kidney disease in the general population: a retrospective study.
Ye M; Hu K; Jin J; Wu D; Hu P; He Q
BMC Nephrol; 2018 Jul; 19(1):190. PubMed ID: 30064367
[TBL] [Abstract][Full Text] [Related]
9. Elevated Serum Uric Acid Level Predicts Rapid Decline in Kidney Function.
Kuwabara M; Bjornstad P; Hisatome I; Niwa K; Roncal-Jimenez CA; Andres-Hernando A; Jensen T; Milagres T; Sato Y; Garcia G; Ohno M; Lanaspa MA; Johnson RJ
Am J Nephrol; 2017; 45(4):330-337. PubMed ID: 28285309
[TBL] [Abstract][Full Text] [Related]
10. Serum uric acid and eGFR_CKDEPI differently predict long-term cardiovascular events and all causes of deaths in a residential cohort.
Puddu PE; Bilancio G; Terradura Vagnarelli O; Lombardi C; Mancini M; Zanchetti A; Menotti A
Int J Cardiol; 2014 Feb; 171(3):361-7. PubMed ID: 24388539
[TBL] [Abstract][Full Text] [Related]
11. Serum uric acid and its association with hypertension, early nephropathy and chronic kidney disease in type 2 diabetic patients.
Fouad M; Fathy H; Zidan A
J Bras Nefrol; 2016 Dec; 38(4):403-410. PubMed ID: 28001185
[TBL] [Abstract][Full Text] [Related]
12. A cohort study on the correlation between serum uric acid trajectory and the progression of renal function in patients with Type 2 diabetes mellitus.
Pan J; Yang Q; Peng J; Li A; Liu Y; Yi B
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):725-732. PubMed ID: 37539575
[TBL] [Abstract][Full Text] [Related]
13. Time-averaged serum uric acid and 10-year incident diabetic kidney disease: A prospective study from China.
Liu L; Gao B; Wang J; Yang C; Wu S; Wu Y; Chen S; Li Q; Zhang H; Wang G; Chen M; Zhao MH; Zhang L
J Diabetes; 2020 Feb; 12(2):169-178. PubMed ID: 31461212
[TBL] [Abstract][Full Text] [Related]
14. Interactive association of serum uric acid and total bilirubin with renal dysfunction among community-dwelling subjects.
Kawamoto R; Ninomiya D; Senzaki K; Kasai Y; Kusunoki T; Ohtsuka N; Kumagi T
Int Urol Nephrol; 2017 Aug; 49(8):1439-1446. PubMed ID: 28573490
[TBL] [Abstract][Full Text] [Related]
15. The effect of baseline serum uric acid on chronic kidney disease in normotensive, normoglycemic, and non-obese individuals: A health checkup cohort study.
Son YB; Yang JH; Kim MG; Jo SK; Cho WY; Oh SW
PLoS One; 2021; 16(1):e0244106. PubMed ID: 33503029
[TBL] [Abstract][Full Text] [Related]
16. Uric acid, renal function and risk of hypoglycaemia in Chinese type 2 diabetes patients.
Ren Y; Ji L; Mu Y; Hong T; Ji Q; Guo L; Huang Q; Yang X
Diabetes Metab Res Rev; 2016 Nov; 32(8):875-882. PubMed ID: 27093645
[TBL] [Abstract][Full Text] [Related]
17. Elevated Serum Uric Acid Is Associated With Greater Risk for Hypertension and Diabetic Kidney Diseases in Obese Adolescents With Type 2 Diabetes: An Observational Analysis From the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study.
Bjornstad P; Laffel L; Lynch J; El Ghormli L; Weinstock RS; Tollefsen SE; Nadeau KJ;
Diabetes Care; 2019 Jun; 42(6):1120-1128. PubMed ID: 30967435
[TBL] [Abstract][Full Text] [Related]
18. A slight increase within the normal range of serum uric acid and the decline in renal function: associations in a community-based population.
Kamei K; Konta T; Hirayama A; Suzuki K; Ichikawa K; Fujimoto S; Iseki K; Moriyama T; Yamagata K; Tsuruya K; Kimura K; Narita I; Kondo M; Asahi K; Watanabe T
Nephrol Dial Transplant; 2014 Dec; 29(12):2286-92. PubMed ID: 25061123
[TBL] [Abstract][Full Text] [Related]
19. High-normal serum uric acid predicts the development of chronic kidney disease in patients with type 2 diabetes mellitus and preserved kidney function.
Kim WJ; Kim SS; Bae MJ; Yi YS; Jeon YK; Kim BH; Song SH; Kim IJ; Kim YK
J Diabetes Complications; 2014; 28(2):130-4. PubMed ID: 24438886
[TBL] [Abstract][Full Text] [Related]
20. Effect of a reduction in uric acid on renal outcomes during losartan treatment: a post hoc analysis of the reduction of endpoints in non-insulin-dependent diabetes mellitus with the Angiotensin II Antagonist Losartan Trial.
Miao Y; Ottenbros SA; Laverman GD; Brenner BM; Cooper ME; Parving HH; Grobbee DE; Shahinfar S; de Zeeuw D; Lambers Heerspink HJ
Hypertension; 2011 Jul; 58(1):2-7. PubMed ID: 21632472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
